Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T B Chen

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Journal of Medicinal Chemistry|October 1, 1986
Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubilityM G Bock, R M DiPardo, K E Rittle, et al.
Neuro-Chirurgie|November 5, 2023
Corrigendum to "A2B5-positive oligodendrocyte precursor cell transplantation improves neurological deficits in rats following spinal cord contusion associated with changes in expression of factors involved in the Notch signaling pathway" [Neurochirurgie 68 (2) (2022) 188-95]H Yuan, C-L Fang, Y-P Deng, et al.
Neuro-Chirurgie|September 20, 2021
A2B5-positive oligodendrocyte precursor cell transplantation improves neurological deficits in rats following spinal cord contusion associated with changes in expression of factors involved in the Notch signaling pathwayH Yuan, C-L Fang, Y-P Deng, et al.
Journal of Medicinal Chemistry|October 15, 1993
A potent, orally active, balanced affinity angiotensin II AT1 antagonist and AT2 binding inhibitorS E de Laszlo, C S Quagliato, W J Greenlee, et al.
European Journal of Pharmacology|July 4, 1998
Characterization of specific binding of [125I]L-762,459, a selective alpha1A-adrenoceptor radioligand to rat and human tissuesS S O'Malley, T B Chen, B E Francis, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 1999
Design and synthesis of novel dihydropyridine alpha-1a antagonistsM R Marzabadi, X Hong, D Nagarathnam, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|September 18, 2018
[KRAS mutations analysis in mucinous epithelial lesions of the endometrium]X Z Zheng, Y Zhan, J H Ma, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonistsJ B Nerenberg, J M Erb, W J Thompson, et al.
Journal of Medicinal Chemistry|December 2, 1999
Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chainsB Lagu, D Tian, D Nagarathnam, et al.
European Journal of Pharmacology|December 8, 2000
In vitro studies on L-771,688 (SNAP 6383), a new potent and selective alpha1A-adrenoceptor antagonistR S Chang, T B Chen, S S O'Malley, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|October 1, 1986
Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubilityM G Bock, R M DiPardo, K E Rittle, et al.
Neuro-Chirurgie|November 5, 2023
Corrigendum to "A2B5-positive oligodendrocyte precursor cell transplantation improves neurological deficits in rats following spinal cord contusion associated with changes in expression of factors involved in the Notch signaling pathway" [Neurochirurgie 68 (2) (2022) 188-95]H Yuan, C-L Fang, Y-P Deng, et al.
Neuro-Chirurgie|September 20, 2021
A2B5-positive oligodendrocyte precursor cell transplantation improves neurological deficits in rats following spinal cord contusion associated with changes in expression of factors involved in the Notch signaling pathwayH Yuan, C-L Fang, Y-P Deng, et al.
Journal of Medicinal Chemistry|October 15, 1993
A potent, orally active, balanced affinity angiotensin II AT1 antagonist and AT2 binding inhibitorS E de Laszlo, C S Quagliato, W J Greenlee, et al.
European Journal of Pharmacology|July 4, 1998
Characterization of specific binding of [125I]L-762,459, a selective alpha1A-adrenoceptor radioligand to rat and human tissuesS S O'Malley, T B Chen, B E Francis, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 1999
Design and synthesis of novel dihydropyridine alpha-1a antagonistsM R Marzabadi, X Hong, D Nagarathnam, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|September 18, 2018
[KRAS mutations analysis in mucinous epithelial lesions of the endometrium]X Z Zheng, Y Zhan, J H Ma, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonistsJ B Nerenberg, J M Erb, W J Thompson, et al.
Journal of Medicinal Chemistry|December 2, 1999
Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chainsB Lagu, D Tian, D Nagarathnam, et al.
European Journal of Pharmacology|December 8, 2000
In vitro studies on L-771,688 (SNAP 6383), a new potent and selective alpha1A-adrenoceptor antagonistR S Chang, T B Chen, S S O'Malley, et al.
Pageof 9